Opinions

Jim Cramer - Mad Money Elanco Animal Health ELAN-N WEAK BUY Feb 26, 2024

Spun off from Eli Lilly in 2018. Reported a mixed report today, including their pet business missing as guidance for the current quarter fell short. They will sell its Aqua business to Merck Animal Health, announced restructuring/job cuts and will increase cash flow conversions four times this year, which is a priority. This gives him some hope in the name.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$16.260

Stock price when the opinion was issued

Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

BUY

Is up 17% in August. It's all about animal health, an enormous industry. They have a fine product pipeline, and all products' revenues have climbed from $350-400 million to $450 million. Cheap at 14x PE and 1x book.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jim Cramer - Mad Money Elanco Animal Health ELAN-N WEAK BUY Feb 26, 2024

You might be interested:

Elanco Animal Health(ELAN-N)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Brendan Caldwell

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase Insights

Jim Cramer - Mad Money